Abstract | BACKGROUND AND AIMS: PATIENTS AND METHODS: A total of sixty-eight patients with hepatocellular carcinoma (stages I and II) participated in the study. Patients were randomized to receive IT (30 patients, control group) or IT+MGN-3 (38 patients), and randomly divided into two groups using a computer-generated randomization list. Patients and investigators were blinded. IT included transarterial oily chemoembolization (TOCE) or a combination of TOCE and percutaneous ethanol injection treatment (PEIT). RESULTS: Patients in the IT+MGN-3 group showed: (i) lower recurrence of the disease, 31.6% (12/38), as compared to 46.7% (14/30) for the control; (ii) higher survival after the second year, 35%, as compared to 6.7% for the control; (iii) significantly lower alpha-fetoprotein level, a 38% decrease (p = 0.0001), as compared to baseline value, while the control showed no significant change; and (iv) a significant decrease in tumor volume, in contrast to the control, which showed no significant change. When the results were analyzed according to each IT modality, MGN-3+IT sub-groups displayed a greater response to treatment, in every aspect examined, than the IT sub-groups alone. However, the patients in the MGN-3+TOCE+PEIT sub-group demonstrated greater reduction in AFP levels and longer survival time than the MGN-3+TOCE sub-group. CONCLUSION:
MGN-3 in conjunction with IT may be useful for the treatment of hepatocellular carcinoma and warrants further investigation in multiple clinical trials.
|
Authors | Mai Hong Bang, Tran Van Riep, Nguyen Tien Thinh, Le Huu Song, Trinh Tuan Dung, Le Van Truong, Le Van Don, Thai Doan Ky, Deyu Pan, Magda Shaheen, Mamdooh Ghoneum |
Journal | Anticancer research
(Anticancer Res)
Vol. 30
Issue 12
Pg. 5145-51
(Dec 2010)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 21187503
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Xylans
- alpha-Fetoproteins
- polysaccharide MGN3
- Ethanol
- Ethiodized Oil
- Doxorubicin
|
Topics |
- Administration, Cutaneous
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Hepatocellular
(drug therapy, pathology, surgery, therapy)
- Catheter Ablation
- Chemoembolization, Therapeutic
(methods)
- Double-Blind Method
- Doxorubicin
(administration & dosage)
- Ethanol
(administration & dosage)
- Ethiodized Oil
(administration & dosage)
- Female
- Humans
- Liver Neoplasms
(drug therapy, pathology, surgery, therapy)
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(pathology)
- Neoplasm Staging
- Xylans
(administration & dosage)
- alpha-Fetoproteins
(metabolism)
|